samedan logo
 
 
spacer
home > epc > Autumn 2018
PUBLICATIONS

European Pharmaceutical Contractor

epc
Autumn 2018

   
Text
PDF
bullet
Legal & Regulatory
Risk-Averse Cultures in New Product Development

Accelerating Development

Brion Regan at ERT discusses the surge in technological developments across the pharmaceutical industry, highlighting that their adoption across the field is low.
 
view
download pdf
Applying Quality Best Practice Principles

Quality Compliance

Patricia Santos-Serrao at MasterControl breaks the traditional view that clinical and manufacturing in life sciences operate in separate spheres by exploring the similarities they share.
 
view
download pdf
Clinical Partnerships in the NHS

Clinical Service

Bernard Ross at Sky Medical Technology puts forward the notion that the pharmaceutical and biotechnology industries need to prioritise clinical partnerships through clinician-first approaches.
 
view
download pdf
Application of Good Clinical Practice Principles

Right First and Every Time

One historic challenge in clinical research has been maintaining the balance between safety and effectiveness. Dr Suzanne Pavon at TFS explores different management approaches to combat this.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

Nemera organized an expert review on the present and future of inhalation products

“Connectivity in every new inhalation device?” This topic was one of those discussed with different inhalation experts - Manfred Keller, Pascal Cavaillon and Henry Chrystyn – during a round table organized by Nemera in Paris to review the advantages and limitations of inhalation devices.
More info >>

White Papers

Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test

Wickham Laboratories Limited

Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >>

Industry Events

Biotech Showcase™ 2019

7-9 January 2019, Hilton San Francisco Union Square

Biotech Showcase™ is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement